MVP vs SPL

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

MVP

MEDICALDEV FPO [MVP]

62MEDIUM-HIGH

SPL

STARPHARMA FPO [SPL]

56MEDIUM

Score Breakdown

MVP SPL
Technical
68
58
Catalyst
50
68
Sentiment
50
50
Fundamental
95
58
Momentum
51
63
Risk Gate
50
50

Key Metrics

MVP Metric SPL
$52.9MMarket Cap$345.9M
214KAvg Volume (20d)2.9M
N/AShort Interest+0.0%
$0.76552-Week High$0.815
$0.36552-Week Low$0.110
+2.2%Daily Change+2.1%
$0.460Reference Price$0.735
+1.1%ROE-45.6%
+1.5%Profit Margin-58.9%

Active Signals

MVP Signals

Stochastic is deep in oversold territory — bounce conditions forming
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Low P/S ratio (1.2x)
Moderate revenue growth (+10%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+10pts)

SPL Signals

Stochastic just turned bullish from a low level — early reversal sign
Death cross triggered — the short-term trend just crossed below the long-term, which is a bearish signal
Volatility is contracting — like a spring being compressed, breakouts often follow
Trading above the 200-day average — the long-term trend is on your side
Strong cash runway (14 quarters)
Revenue in sharp decline (-56%)
Piotroski F-Score weak (3/9, low-confidence approx)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare MVP and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AHC vs CGS →ARX vs IMM →ATX vs IMM →AVE vs CUV →AVE vs MVP →
MVP Full Analysis → SPL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).